November 2016

Newsletter-Banner

ACT-AD Held Its Ninth Annual FDA/AD Allies Meeting on November 16

The ACT-AD Coalition held its Ninth Annual FDA/AD Allies Meeting on November 16 in North Bethesda, Md., to discuss the current state of Alzheimer’s disease treatment. The theme of this year’s meeting was “Starting with the End in Mind: Aligning the Science to Close Gaps in Alzheimer’s Disease Therapeutic Development.” For a recap of the meeting, go here.

FDA Launches New Website to Help Bring Neurological Medical Devices to the Marketplace

On November 10, the U.S. Food & Drug Administration (FDA) launched a website to help sponsors and innovators bring neurological medical devices to the U.S. marketplace. The new site is part of the FDA’s support of the White House BRAIN (Brain Research through Advancing Innovative Neurotechnologies) Initiative that focuses on new ways to treat and cure brain disorders. Visit the new website here.

Loneliness May Play Causative Role in Alzheimer’s Disease 

In a recently published study in JAMA Psychiatry, researchers found that a higher amyloid burden was linked to feelings of isolation, being left out, and lacking companionship among older adults. According to the researchers, the study suggests that loneliness is a “neuropsychiatric symptom relevant to preclinical AD.” To learn more about the study, go here.

NIA Grant Awarded to Examine Link Between Exercise, Brain Health, and Aging

The National Institute on Aging awarded a 5-year, $21.8 million grant to the University of Pittsburgh’s Dr. Kirk Erickson to study the association between brain health and exercise in older adults. Learn more here.

Join The Hill for a Briefing on America’s Alzheimer’s Goals, December 1

The Hill will host “Race Against Time: Overcoming Alzheimer’s by 2025” on December 1, from 8:00 a.m. to 10 a.m. Sen. Thom Tillis and Rep. Paul Tonko will lead a panel discussion on how far we have progressed in the fight against Alzheimer’s and where future efforts should be focused. Panelists include ACT-AD Science Advisory Board Member Dr. Paul Aisen, Alzheimer’s Therapeutic Research Institute, Maria Carillo, Alzheimer’s Association, Teresa Osborne, Pennsylvania Department of Aging, and Linda Elam, U.S. Department of Health & Human Services. The briefing is sponsored by the Alzheimer’s Readiness Project, an initiative of Eli Lilly & Co. More information can be found here.

Cure Alzheimer’s Fund Hosts Webinar with NIA’s Dr. Richard Hodes, December 5

Cure Alzheimer’s Fund President & CEO Tim Armour and NIA Director Dr. Richard Hodes will discuss public and private funding for Alzheimer’s disease research during a webinar on December 5, 2016 at 1:30 p.m. You can join the webinar by visiting the Cure Alzheimer’s Fund website here.

Save the Date for the Cognitive Aging Summit III, April 6-7

Convened by the National Institute on Aging, the Cognitive Aging Summit III “will bring together experts in a variety of research fields to discuss the most cutting edge advances in our understanding of age-related brain and cognitive changes, with a particular focus on resilience and reserve.” For more information, please go here.